Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

AstraZeneca PLC thrives with $54B revenue and 14 blockbusters in 2024, fueled by oncology and rare disease growth. Click for ...

Akums reports Q1 FY26 total income of Rs. 1,051 crore with 2.4% growth, 19% YoY adjusted EBITDA growth: Our Bureau, Bengaluru Tuesday, August 12, 2025, 15:30 Hrs [IST] Akums Drugs ...

In Q1 FY26, Akums reported total income of Rs. 1,051 crore, with healthy Adj EBITDA of Rs. 156 crore reflecting a robust 19.1 ...

The BSE Sensex surged 746 points (0.93%) to close at 80,604.08 on Monday, driven by strong buying in oil, auto, and banking stocks, alongside fresh foreign fund inflows.

The drug clocked Rs 47-crore sales in July, double its June figure, according to data from prescriptions tracker PharmaTrac.

Pharmexcil and Mexican Consulate join hands to chart new avenues for Indian pharma expansion: Shardul Nautiyal, Mumbai Tuesday, August 12, 2025, 08:00 Hrs [IST] In a bid to unlock ...

The findings suggest that patients with type 2 diabetes treated with GLP-1 agonists require regular screening and monitoring ...

Lilly is on track to file its oral GLP-1 agonist orforglipron for type 2 diabetes next year after presenting the first phase 3 data with the drug.

The new label for Forxiga/Farxiga (dapagliflozin) comes from the DECLARE-TIMI 58 trial, and the EU is the first major market to approve the label update, ahead of the US and China where it remains ...

Q: I have Type 2 diabetes, and my doctor insists that I give up beverages with almost all sugar substitutes and stick with water. Can you explain what’s wrong with ...

I was born in 1954, and my mother took diethylstilbestrol (DES) to prevent miscarriages. I had a hysterectomy last year, and ...